Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C11orf49 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
mRNA | COL1A1 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
mRNA | KLK6 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
mRNA | MYPOP | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
mRNA | DRC1 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
mRNA | TBXA2R | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
mRNA | PLEKHN1 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
mRNA | ATAD3A | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
mRNA | TSTD2 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
mRNA | RAD51AP1 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |